Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Times of India
The Times of India
Lifestyle
TIMESOFINDIA.COM

Coronavirus: UK approves Moderna vaccine targeting Omicron variant, key points to know

The UK's Medicine and Healthcare products Regulatory Agency (MHRA) has approved an updated Moderna vaccine against the coronavirus' Omicron variant.

In an official statement, Moderna vaccine has announced that: the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted conditional authorization for the use of the Omicron-containing bivalent COVID-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron) as a booster dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.